# KALA BIO, Inc.: Form 8-K, filed Dec 16, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: 8-K
- Filed: 2025-12-16
- Accepted by EDGAR: Dec 16, 2025, 13:28 ET
- Period: 2025-12-15
- Accession: 0001829126-25-010045
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/kalabio_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/kalabio_8k.htm

Filed Dec 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001829126-25-010045. Last ingested by Listed: Nov 9, 2026, 18:14 ET. No prices; not investment advice.